Vitamin Blue Profit Margin

Vitamin Blue (VTMB) currently reports a profit margin of -28.48% as of June 2018. That compares with -16.17% in the prior-year period — down 76.2% year over year. That is below the sector sector average of 13.09%. Use the charts on this page to explore Vitamin Blue's profit margin history and peer comparisons.

Vitamin Blue's profit margin decreased from -16.17% to -28.48% — a 76.2% year-over-year decrease (period ending June 2018). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vitamin Blue's profit margin of -28.48% is lower than the its sector sector average of 13.09%. That is roughly 317.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Vitamin Blue's current -28.48% should be judged against industry norms (sector average: 13.09%) and against VTMB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -28.48%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.09%. From there, open related valuation or income-statement pages for Vitamin Blue, and consider following VTMB for alerts when major investors trade the stock.